Ovintiv Inc. (NYSE: OVV) reached a new 52-week high on February 26, 2024, trading as high as $52.39 before settling at $51.84. This marked a significant increase from the previous closing price of $50.59, with approximately 1,097,006 shares exchanged during the trading session.
The surge in Ovintiv’s stock price can be attributed to several recent upgrades from prominent financial analysts. Notably, UBS Group raised its price target on Ovintiv shares from $58.00 to $61.00 and assigned a “buy” rating in a report dated February 25, 2024. Similarly, Barclays increased its price objective from $55.00 to $58.00, also giving the company an “overweight” rating on the same day.
In addition, Jefferies Financial Group reaffirmed a “buy” rating with a price target of $54.00, while William Blair initiated coverage with an “outperform” rating and a target of $50.00. Although Citigroup adjusted its target price down from $54.00 to $52.00, it maintained a “buy” rating for the stock. Currently, the consensus rating for Ovintiv among analysts stands at “Moderate Buy,” with a consensus price target of $52.72, according to MarketBeat.com.
Financial Performance and Dividend Announcement
On February 23, 2024, Ovintiv reported its quarterly earnings, showcasing a robust performance with earnings per share of $1.39, exceeding analysts’ expectations of $0.98 by $0.41. The company generated revenue of $1.89 billion, aligning with analysts’ forecasts. This quarter’s results marked a notable improvement compared to the same period last year, when the company reported a loss of ($0.23) per share.
In a further positive development, Ovintiv declared a quarterly dividend of $0.30, set to be paid on March 31, 2024, to shareholders recorded as of March 13, 2024. This dividend equates to an annualized total of $1.20, offering a dividend yield of 2.3%. The company currently maintains a dividend payout ratio (DPR) of 24.79%.
Insider Trading and Institutional Holdings
In recent insider trading activity, Chief Operating Officer Gregory Dean Givens sold 50,000 shares of Ovintiv on December 12, 2023, at an average price of $40.33, totaling approximately $2,016,500. Following this transaction, Givens holds 105,867 shares valued at around $4,269,616, reflecting a 32.08% reduction in his ownership.
Institutional investors have shown significant interest in Ovintiv, with several large firms adjusting their positions. AQR Capital Management LLC increased its stake by 263.8% during the third quarter, now owning 4,949,637 shares valued at $199,866,000. Millennium Management LLC also boosted its holdings by 116.3%, holding 5,692,806 shares worth $223,101,000 after acquiring 3,060,691 additional shares.
Overall, institutional and hedge fund ownership now accounts for 83.81% of Ovintiv’s stock, indicating strong support from major investors.
Ovintiv Inc., headquartered in Denver, Colorado, focuses on the exploration, development, and production of oil and natural gas. The company, formerly known as Encana Corporation, rebranded in January 2020 and has since aimed to capitalize on high-return projects across various shale basins in North America. As Ovintiv continues to navigate the energy landscape, its recent stock performance and analyst endorsements reflect growing confidence in its business strategy and market position.
